Who Owns Structure Therapeutics Stock?
NASDAQ: GPCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 3:51 PM ET
Ownership breakdown
- Held by institutions
- 97.70%
- Institutions (% of float)
- 100.83%
- Held by insiders
- 3.11%
- Institutional holders
- 269
- Institutions 96.9%
- Insiders 3.1%
- Public and other 0.0%
Who owns Structure Therapeutics stock?
Institutional investors own about 97.7% of Structure Therapeutics's shares, spread across 269 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.11% of GPCR.
The largest institutional holders are FMR, LLC (11.22%), Wellington Management Group, LLP (10.60%) and Avoro Capital Advisors LLC (9.42%). Together, the top 10 institutions control 62.5% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their GPCR positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of GPCR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 7.81M | 11.22% | -7.1% |
| Wellington Management Group, LLP | 7.38M | 10.60% | +1.6% |
| Avoro Capital Advisors LLC | 6.56M | 9.42% | 0.0% |
| Jupiter Topco LLC | 5.20M | 7.48% | +100.0% |
| Deep Track Capital, Lp | 4.74M | 6.81% | +10.8% |
| BVF Inc. | 3.37M | 4.84% | -2.7% |
| Morgan Stanley | 2.81M | 4.03% | +21.7% |
| Orbimed Advisors LLC. | 2.21M | 3.17% | +49.8% |
| Principal Financial Group, Inc. | 1.75M | 2.52% | -0.1% |
| American Century Companies Inc | 1.68M | 2.42% | +17.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of GPCR
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 3.28M | 4.71% |
| American Century Mutual Funds, Inc.-HERITAGE FUND | 967.35K | 1.39% |
| Fidelity Advisor Series I-Fidelity Advisor Growth Opportunities Fund | 733.50K | 1.05% |
| Principal Funds, Inc-Global Emerging Markets Fund | 625.75K | 0.90% |
| Variable Insurance Products Fund II-VIP Contrafund Portfolio | 595.00K | 0.85% |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 549.35K | 0.79% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 542.04K | 0.78% |
| Fidelity Contrafund-Fidelity Advisor New Insights Fund | 539.60K | 0.78% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 527.90K | 0.76% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 500.00K | 0.72% |
Frequently asked questions
Who is the largest shareholder of Structure Therapeutics?
FMR, LLC is the largest institutional shareholder of GPCR, owning 11.22% of shares outstanding (7.81M shares) as of its latest 13F filing.
What percentage of Structure Therapeutics is owned by institutions?
Institutions own about 97.7% of GPCR shares and 100.8% of the public float.
How much of Structure Therapeutics do insiders own?
Insiders, such as officers and directors, own about 3.11% of GPCR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.